The Board of Directors of BrightGene Bio-Medical Technology Co., Ltd. has authorized a buyback plan on February 6, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
35.74 CNY | -5.52% | +2.61% | +2.11% |
May. 07 | China Shares Rise as Property Market Gets Relief; BrightGene Jumps 7% | MT |
May. 07 | BrightGene to Sell 500 Million Yuan Shares to Actual Controller; Shares Up 3% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.11% | 2.2B | |
+38.70% | 728B | |
+33.05% | 603B | |
-5.60% | 360B | |
+18.87% | 332B | |
+1.27% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.56% | 164B |
- Stock Market
- Equities
- 688166 Stock
- News BrightGene Bio-Medical Technology Co., Ltd.
- BrightGene Bio-Medical Technology Co., Ltd. authorizes a Buyback Plan.